基本信息

产品名称	Recombinant Retinoic Acid Receptor alpha Antibody
别名	Anti-Retinoic Acid Receptor alpha抗体 \| Retinoic Acid Receptor alpha抗体 \| 维甲酸受体α(RARa)单克隆抗体 \| Anti-Retinoic Acid Receptor alpha抗体 \| Retinoic Acid Receptor alpha抗体 \| 维甲酸受体α(RARa)单克隆抗体 \| 重组视黄酸受体α抗体
英文别名	alpha polypeptide \| NR1B1 \| RAR alpha \| RARA \| RAR-alpha \| retinoic acid receptor, alpha \| RAR \| RARalpha \| NR1B1 antibody \| Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein antibody \| Nuclear receptor subfamily 1 group B memb
规格或纯度	ExactAb™, Validated, 重组, 1.0 mg/mL
宿主种属	兔(Rabbit)
特异性	RARA
种属反应性	人(Human),大鼠(Rat),小鼠(Mouse)
免疫原	A synthetic peptide derived from human Retinoic Acid Receptor alpha (AA 5-30)
阳性对照	WB: Mouse brain, MCF7, Hep G2, HEK293 and C6 lysates.
偶联	Unconjugated

产品属性

克隆类型	重组抗体
Format	Whole IgG
亚型	Rabbit IgG
轻链亚型	kappa
SDS-PAGE	150 kDa
纯化方法	Protein A purified
物理外观	Liquid
储存缓冲液	10mM PBS, 150mM NaCl, 50% Glycerol, 0.05% BSA, 0.02% Sodium azide, pH 7.4
防腐剂	0.02% Sodium azide
浓度	1.0 mg/mL
储存温度	-20°C储存,避免反复冻融
运输条件	超低温冰袋运输
稳定性与储存	4°C 短期储存（1-2 周）。-20°C下长期保存（24个月）。收货后建议分装。避免冷冻/解冻循环。
分子类型	抗体

关联靶点（人）

RARA Tclin 视黄酸受体α(Retinoic acid receptor alpha) (0 活性数据)

点击查看靶蛋白信息： RARA

活性类型	活性值-log(M)	作用机制	期刊	参考文献(PubMed IDs)

RARA Tclin Retinoic acid receptor alpha (1324 活性数据)

点击查看靶蛋白信息： RARA

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

作用机制

作用机制	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	参考文献

图片

Western Blot: Recombinant Retinoic Acid Receptor alpha Antibody (Ab125108)

Recombinant Retinoic Acid Receptor alpha Antibody (Ab125108) - Western Blot
All lanes: Recombinant Retinoic Acid Receptor alpha Antibody (Ab125108) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution
Predicted band size: 51 kDa
Observed band size: 59 kDa
Exposure time: 100.0 s

Western Blot: Recombinant Retinoic Acid Receptor alpha Antibody (Ab125108)

应用

应用名称	稀释比例
WB	1/500-1/1000

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):

输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到2个结果

批号(Lot Number)	证书类型	货号
ZJ24F0505731	分析证书	Ab125108
ZJ24F0505730	分析证书	Ab125108

技术文档和文章

蛋白质印迹的一抗选择指南

Categories: 实验方案（Protocols）

探索主题:

重组抗体单克隆抗体多克隆抗体蛋白质印迹内参抗体一抗选择

Guidelines of Primary Antibodies for Western Blotting

Categories: 实验方案（Protocols）

探索主题:

Western blotting Monoclonal antibodies Recombinant Antibodies Polyclonal Antibodies Primary Antibodies Selection Loading Controls

Guidelines of Primary Antibodies for Western Blotting

Categories: 实验方案（Protocols）

探索主题:

Western blotting Monoclonal antibodies Recombinant Antibodies Polyclonal Antibodies Primary Antibodies Selection Loading Controls

高分子量蛋白质印迹法

Categories: 实验方案（Protocols）

探索主题:

免疫印迹生物缓冲液蛋白质印迹高分子量蛋白大分子蛋白蛋白质电泳 WB抗体

Protocol of Western Blotting For High Molecular Weights

Categories: 实验方案（Protocols）

探索主题:

Western blotting Biological buffer Immunoblotting Protein Electrophoresis High Molecular Weights large molecular proteins WB antibody

Protocol of Western Blotting For High Molecular Weights

Categories: 实验方案（Protocols）

探索主题:

Western blotting Biological buffer Immunoblotting Protein Electrophoresis High Molecular Weights large molecular proteins WB antibody

Protocol of Western Blotting For High Molecular Weights

Categories: 实验方案（Protocols）

探索主题:

Western blotting Biological buffer Immunoblotting Protein Electrophoresis High Molecular Weights large molecular proteins WB antibody

Protocol of Western Blotting For High Molecular Weights

Categories: 实验方案（Protocols）

探索主题:

Western blotting Biological buffer Immunoblotting Protein Electrophoresis High Molecular Weights large molecular proteins WB antibody

引用文献

1. Zhang L, Nadzan AM, Heyman RA, Love DL, Mais DE, Croston G, Lamph WW, Boehm MF.. (1996) Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.. J Med Chem, 39 (14): (2659-2663). [PMID:8709094] [10.1021/jm960285j]
2. Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM.. (1999) Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.. J Med Chem, 42 (21): (4434-4445). [PMID:10543887] [10.1021/jm990292i]
3. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, John H, Richter R, Schleuder D, Meyer M, Forssmann WG. (2003) Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.. FEBS Lett, 555 (3): (495-9). [PMID:14675762]
4. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.. Cell, 90 (3): (569-80). [PMID:9267036]
5. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. (2000) Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.. Mol Cell, 5 (2): (289-98). [PMID:10882070]
6. Brand NJ, Petkovich M, Chambon P. (1990) Characterization of a functional promoter for the human retinoic acid receptor-alpha (hRAR-alpha).. Nucleic Acids Res, 18 (23): (6799-806). [PMID:2175878]
7. Giguere V, Ong ES, Segui P, Evans RM. (1987) Identification of a receptor for the morphogen retinoic acid.. Nature, 330 (6149): (624-9). [PMID:2825036]
8. Petkovich M, Brand NJ, Krust A, Chambon P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors.. Nature, 330 (6147): (444-50). [PMID:2825025]
9. Thacher SM, Vasudevan J, Chandraratna RA. (2000) Therapeutic applications for ligands of retinoid receptors.. Curr Pharm Des, 6 (1): (25-58). [PMID:10637371]
10. Qi C, Chang J, Zhu Y, Yeldandi AV, Rao SM, Zhu YJ. (2002) Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.. J Biol Chem, 277 (32): (28624-30). [PMID:12039952]
11. Shao W, Halachmi S, Brown M. (2002) ERAP140, a conserved tissue-specific nuclear receptor coactivator.. Mol Cell Biol, 22 (10): (3358-72). [PMID:11971969]
12. Canan Koch SS, Dardashti LJ, Cesario RM, Croston GE, Boehm MF, Heyman RA, Nadzan AM. (1999) Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.. J Med Chem, 42 (4): (742-50). [PMID:10052980]
13. Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, Kallioniemi OP, Kononen J, Trent JM, Azorsa D, Jhun BH, Cheong JH, Lee YC, Meltzer PS, Lee JW. (1999) A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.. J Biol Chem, 274 (48): (34283-93). [PMID:10567404]
14. le Maire A, Teyssier C, Erb C, Grimaldi M, Alvarez S, de Lera AR, Balaguer P, Gronemeyer H, Royer CA, Germain P, Bourguet W. (2010) A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.. Nat Struct Mol Biol, 17 (7): (801-7). [PMID:20543827]
15. Wagner CE, Jurutka PW, Marshall PA, Groy TL, van der Vaart A, Ziller JW, Furmick JK, Graeber ME, Matro E, Miguel BV et al.. (2009) Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).. J Med Chem, 52 (19): (5950-66). [PMID:19791803]
16. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, Shin Y, Liu J, Cameron MD, Noel R et al.. (2012) Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.. Nature, 485 (7396): (62-8). [PMID:22460951]
17. Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, Déret S, Dreno B, Gamboa B, Jomard A, Luzy AP et al.. (2018) Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.. Br J Dermatol, 179 (2): (442-456). [PMID:29974453]
18. Schierle S, Neumann S, Heitel P, Willems S, Kaiser A, Pollinger J, Merk D. (2020) Design and Structural Optimization of Dual FXR/PPARδ Activators.. J Med Chem, 63 (15): (8369-8379). [PMID:32687365]
19. Santiago Pérez-Rodríguez,Maria A Ortiz,Raquel Pereira,Fátima Rodríguez-Barrios,Angel R de Lera,F Javier Piedrafita. (2009-02-14) Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles.. European journal of medicinal chemistry, 44 ((6)): (2434-2446). [PMID:19216008]
20. Zebin Xia,Lulu Farhana,Ricardo G Correa,Jayanta K Das,David J Castro,Jinghua Yu,Robert G Oshima,John C Reed,Joseph A Fontana,Marcia I Dawson. (2011-05-10) Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid.. Journal of medicinal chemistry, 54 ((11)): (3793-3816). [PMID:21548569]
21. Fuminori Ohsawa, Shoya Yamada, Nobumasa Yakushiji, Ryosuke Shinozaki, Mariko Nakayama, Kohei Kawata, Manabu Hagaya, Toshiki Kobayashi, Kazutaka Kohara, Yuuki Furusawa, Chisa Fujiwara, Yui Ohta, Makoto Makishima, Hirotaka Naitou, Akihiro Tai, Yutaka Yoshikawa, Hiroyuki Yasui, Hiroki Kakuta,. (2013-02-09) Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.. Journal of medicinal chemistry, 56 ((5)): ( 1865-1877 ). [PMID:23391145]
22. Haffner CD, Lenhard JM, Miller AB, McDougald DL, Dwornik K, Ittoop OR, Gampe RT, Xu HE, Blanchard S, Montana VG, Consler TG, Bledsoe RK, Ayscue A, Croom D.. (2004) Structure-based design of potent retinoid X receptor alpha agonists.. J Med Chem, 47 (8): (2010-2029). [PMID:15056000] [10.1021/jm030565g]
23. Shen L, Zhang Y, Wang A, Sieber-McMaster E, Chen X, Pelton P, Xu JZ, Yang M, Zhu P, Zhou L, Reuman M, Hu Z, Russell R, Gibbs AC, Ross H, Demarest K, Murray WV, Kuo GH.. (2007) Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors alpha and delta.. J Med Chem, 50 (16): (3954-3963). [PMID:17608467] [10.1021/jm070511x]
24. Montanari R, Saccoccia F, Scotti E, Crestani M, Godio C, Gilardi F, Loiodice F, Fracchiolla G, Laghezza A, Tortorella P, Lavecchia A, Novellino E, Mazza F, Aschi M, Pochetti G.. (2008) Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.. J Med Chem, 51 (24): (7768-7776). [PMID:19053776] [10.1021/jm800733h]
25. Lorenzo P, Alvarez R, Ortiz MA, Alvarez S, Piedrafita FJ, de Lera AR.. (2008) Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids.. J Med Chem, 51 (17): (5431-5440). [PMID:18702457] [10.1021/jm800285f]
26. Fujii S, Ohsawa F, Yamada S, Shinozaki R, Fukai R, Makishima M, Enomoto S, Tai A, Kakuta H.. (2010) Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.. Bioorg Med Chem Lett, 20 (17): (5139-5142). [PMID:20656484] [10.1016/j.bmcl.2010.07.012]
27. Patch RJ, Searle LL, Kim AJ, De D, Zhu X, Askari HB, O'Neill JC, Abad MC, Rentzeperis D, Liu J, Kemmerer M, Lin L, Kasturi J, Geisler JG, Lenhard JM, Player MR, Gaul MD.. (2011) Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.. J Med Chem, 54 (3): (788-808). [PMID:21218783] [10.1021/jm101063h]
28. Itoh Y, Ishikawa M, Kitaguchi R, Okuhira K, Naito M, Hashimoto Y.. (2012) Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist.. Bioorg Med Chem Lett, 22 (13): (4453-4457). [PMID:22658364] [10.1016/j.bmcl.2012.04.134]
29. Batie S, Lee JH, Jama RA, Browder DO, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Mohammed Z, Trang V, Marshall PA, Jurutka PW, Wagner CE.. (2013) Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists.. Bioorg Med Chem, 21 (3): (693-702). [PMID:23276449] [10.1016/j.bmc.2012.11.033]
30. Jetson R, Malik N, Luniwal A, Chari V, Ratnam M, Erhardt P.. (2013) Practical synthesis of a chromene analog for use as a retinoic acid receptor alpha antagonist lead compound.. Eur J Med Chem, 63 (104-108). [PMID:23474897] [10.1016/j.ejmech.2013.02.012]
31. Desphande A, Xia G, Boerma LJ, Vines KK, Atigadda VR, Lobo-Ruppert S, Grubbs CJ, Moeinpour FL, Smith CD, Christov K, Brouillette WJ, Muccio DD.. (2014) Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.. Bioorg Med Chem, 22 (1): (178-185). [PMID:24359708] [10.1016/j.bmc.2013.11.039]
32. García-Rodríguez J, Pérez-Rodríguez S, Ortiz MA, Pereira R, de Lera AR, Piedrafita FJ.. (2014) Inhibition of IκB kinase-β and IκB kinase-α by heterocyclic adamantyl arotinoids.. Bioorg Med Chem, 22 (4): (1285-1302). [PMID:24457093] [10.1016/j.bmc.2014.01.006]
33. Tanabe H, Yasui T, Kotani H, Nagatsu A, Makishima M, Amagaya S, Inoue M.. (2014) Retinoic acid receptor agonist activity of naturally occurring diterpenes.. Bioorg Med Chem, 22 (12): (3204-3212). [PMID:24799257] [10.1016/j.bmc.2014.03.047]
34. Atigadda VR, Xia G, Desphande A, Boerma LJ, Lobo-Ruppert S, Grubbs CJ, Smith CD, Brouillette WJ, Muccio DD.. (2014) Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.. J Med Chem, 57 (12): (5370-5380). [PMID:24801499] [10.1021/jm5004792]
35. Gege C, Schlüter T, Hoffmann T.. (2014) Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.. Bioorg Med Chem Lett, 24 (22): (5265-5267). [PMID:25305688] [10.1016/j.bmcl.2014.09.053]
36. Ye N, Ding Y, Wild C, Shen Q, Zhou J.. (2014) Small molecule inhibitors targeting activator protein 1 (AP-1).. J Med Chem, 57 (16): (6930-6948). [PMID:24831826] [10.1021/jm5004733]
37. Chen F, Liu J, Huang M, Hu M, Su Y, Zhang XK.. (2014) Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site.. ACS Med Chem Lett, 5 (7): (736-741). [PMID:25057340] [10.1021/ml5000405]
38. Soldi R, Horrigan SK, Cholody MW, Padia J, Sorna V, Bearss J, Gilcrease G, Bhalla K, Verma A, Vankayalapati H, Sharma S.. (2015) Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors.. J Med Chem, 58 (15): (5854-5862). [PMID:26182238] [10.1021/acs.jmedchem.5b00460]
39. Hirata K, Kotoku M, Seki N, Maeba T, Maeda K, Hirashima S, Sakai T, Obika S, Hori A, Hase Y, Yamaguchi T, Katsuda Y, Hata T, Miyagawa N, Arita K, Nomura Y, Asahina K, Aratsu Y, Kamada M, Adachi T, Noguchi M, Doi S, Crowe P, Bradley E, Steensma R, Tao H, Fenn M, Babine R, Li X, Thacher S, Hashimoto H, Shiozaki M.. (2016) SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious RORγ Inhibitor.. ACS Med Chem Lett, 7 (1): (23-27). [PMID:26819660] [10.1021/acsmedchemlett.5b00253]
40. Sundén H, Schäfer A, Scheepstra M, Leysen S, Malo M, Ma JN, Burstein ES, Ottmann C, Brunsveld L, Olsson R.. (2016) Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.. J Med Chem, 59 (3): (1232-1238). [PMID:26820900] [10.1021/acs.jmedchem.5b01702]
41. Diaz P, Huang W, Keyari CM, Buttrick B, Price L, Guilloteau N, Tripathy S, Sperandio VG, Fronczek FR, Astruc-Diaz F, Isoherranen N.. (2016) Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.. J Med Chem, 59 (6): (2579-2595). [PMID:26918322] [10.1021/acs.jmedchem.5b01780]
42. Hughes NE, Bleisch TJ, Jones SA, Richardson TI, Doti RA, Wang Y, Stout SL, Durst GL, Chambers MG, Oskins JL, Lin C, Adams LA, Page TJ, Barr RJ, Zink RW, Osborne H, Montrose-Rafizadeh C, Norman BH.. (2016) Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design.. Bioorg Med Chem Lett, 26 (14): (3274-3277). [PMID:27261179] [10.1016/j.bmcl.2016.05.056]
43. Schmidt J, Rotter M, Weiser T, Wittmann S, Weizel L, Kaiser A, Heering J, Goebel T, Angioni C, Wurglics M, Paulke A, Geisslinger G, Kahnt A, Steinhilber D, Proschak E, Merk D.. (2017) A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.. J Med Chem, 60 (18): (7703-7724). [PMID:28845983] [10.1021/acs.jmedchem.7b00398]
44. Flesch D, Cheung SY, Schmidt J, Gabler M, Heitel P, Kramer J, Kaiser A, Hartmann M, Lindner M, Lüddens-Dämgen K, Heering J, Lamers C, Lüddens H, Wurglics M, Proschak E, Schubert-Zsilavecz M, Merk D.. (2017) Nonacidic Farnesoid X Receptor Modulators.. J Med Chem, 60 (16): (7199-7205). [PMID:28749691] [10.1021/acs.jmedchem.7b00903]
45. Teno N, Yamashita Y, Iguchi Y, Fujimori K, Une M, Nishimaki-Mogami T, Hiramoto T, Gohda K.. (2018) Nonacidic Chemotype Possessing N-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) Antagonists.. ACS Med Chem Lett, 9 (2): (78-83). [PMID:29456791] [10.1021/acsmedchemlett.7b00363]
46. Nomura S, Endo-Umeda K, Fujii S, Makishima M, Hashimoto Y, Ishikawa M.. (2018) Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.. Bioorg Med Chem Lett, 28 (4): (796-801). [PMID:29398545] [10.1016/j.bmcl.2017.12.024]
47. Haffez H, Chisholm DR, Tatum NJ, Valentine R, Redfern C, Pohl E, Whiting A, Przyborski S.. (2018) Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids.. Bioorg Med Chem, 26 (8): (1560-1572). [PMID:29439915] [10.1016/j.bmc.2018.02.002]
48. Teno N, Yamashita Y, Masuda A, Iguchi Y, Oda K, Fujimori K, Hiramoto T, Nishimaki-Mogami T, Une M, Gohda K.. (2019) Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists.. Bioorg Med Chem, 27 (11): (2220-2227). [PMID:31029550] [10.1016/j.bmc.2019.04.029]
49. Hernandez-Olmos V, Knape T, Heering J, von Knethen A, Kilu W, Kaiser A, Wurglics M, Helmstädter M, Merk D, Schubert-Zsilavecz M, Parnham MJ, Steinhilber D, Proschak E.. (2019) Structure optimization of a new class of PPARγ antagonists.. Bioorg Med Chem, 27 (21): (115082-115082). [PMID:31548084] [10.1016/j.bmc.2019.115082]
50. Passeri D, Carotti A, Pittol JMR, Ciaccioli G, Pellicciari R, van Mil SWC, Gioiello A.. (2019) Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.. Medchemcomm, 10 (8): (1412-1419). [PMID:31673308] [10.1039/C9MD00264B]
51. Masuda A, Gohda K, Iguchi Y, Fujimori K, Yamashita Y, Oda K, Une M, Teno N.. (2020) N¹-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR).. Bioorg Med Chem, 28 (14): (115512-115512). [PMID:32616182] [10.1016/j.bmc.2020.115512]
52. Hartmann M, Bibli SI, Tews D, Ni X, Kircher T, Kramer JS, Kilu W, Heering J, Hernandez-Olmos V, Weizel L, Scriba GKE, Krait S, Knapp S, Chaikuad A, Merk D, Fleming I, Fischer-Posovszky P, Proschak E.. (2021) Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator.. J Med Chem, 64 (5.0): (2815-2828). [PMID:33620196] [10.1021/acs.jmedchem.0c02063]
53. Vollberg, T M TM and 5 more authors.. (1992) Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation.. Molecular endocrinology (Baltimore, Md.), [PMID:1318502]
54. Zitnik, R J RJ and 6 more authors.. (1994) Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts.. Journal of immunology (Baltimore, Md. : 1950), (1): [PMID:8301142]
55. Chen, Z Z and 9 more authors.. (1994) PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.. Proceedings of the National Academy of Sciences of the United States of America, (1): [PMID:8302850]
56. Redner, R L RL, Rush, E A EA, Faas, S S, Rudert, W A WA and Corey, S J SJ.. (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.. Blood, (1): [PMID:8562957]
57. and Chandraratna, R A RA.. (1996) Tazarotene--first of a new generation of receptor-selective retinoids.. The British journal of dermatology, [PMID:9035701]
58. Orfanos, C E CE, Zouboulis, C C CC, Almond-Roesler, B B and Geilen, C C CC.. (1997) Current use and future potential role of retinoids in dermatology.. Drugs, [PMID:9074840]
59. Tian, K K, Norris, A W AW, Lin, C L CL and Li, E E.. (1997) The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.. Biochemistry, (13): [PMID:9153406]
60. Shroot, B B and Michel, S S.. (1997) Pharmacology and chemistry of adapalene.. Journal of the American Academy of Dermatology, [PMID:9204085]
61. Vu-Dac, N N and 8 more authors.. (1998) Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.. The Journal of clinical investigation, (1): [PMID:9691099]
62. Hjalt, T A TA and Murray, J C JC.. (1999) Genomic structure of the human retinoic acid receptor-alpha1 gene.. Mammalian genome : official journal of the International Mammalian Genome Society, [PMID:10337631]
63. Rastinejad, F F, Wagner, T T, Zhao, Q Q and Khorasanizadeh, S S.. (2000) Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.. The EMBO journal, (1): [PMID:10698945]
64. Dahl, A R AR and 9 more authors.. (2000) Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study.. Clinical cancer research : an official journal of the American Association for Cancer Research, [PMID:10955779]
65. Wang, Q Q and 6 more authors.. (2001) 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.. Breast cancer research and treatment, [PMID:11519864]
66. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ.. (2002) TTD: Therapeutic Target Database.. Nucleic acids research, (1): [PMID:11752352]
67. Parrado, A A and 12 more authors.. (2001) Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.. Nucleic acids research, (15): [PMID:11812818]
68. Fujita, Kazuhiro K and 6 more authors.. (2003) Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia: structure of the fusion point in a case lacking classic t(15;17) translocation.. Leukemia & lymphoma, [PMID:12691149]
69. Yen, Andrew A, Fenning, Robert R, Chandraratna, Roshantha R, Walker, Patricia P and Varvayanis, Susi S.. (2004) A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.. Molecular pharmacology, [PMID:15383624]
70. Cao, Xihua X and 8 more authors.. (2004) Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting.. Molecular and cellular biology, [PMID:15509776]
71. Kim, Young-Eui YE and 5 more authors.. (2005) Requirement of the coiled-coil domain of PML-RARalpha oncoprotein for localization, sumoylation, and inhibition of monocyte differentiation.. Biochemical and biophysical research communications, (13): [PMID:15809060]
72. Sanda, T T and 9 more authors.. (2005) Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.. Leukemia, [PMID:15843826]
73. Baumann, Leslie L and 8 more authors.. (2005) Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.. Cutis, [PMID:16144296]
74. Epping, Mirjam T MT and 5 more authors.. (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.. Cell, (23): [PMID:16179254]
75. Srinivas, Harish H and 8 more authors.. (2006) Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.. The Biochemical journal, (1): [PMID:16417524]
76. Ritter, M M and 16 more authors.. (2006) Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia.. Leukemia, [PMID:16424870]
77. Cho, Yang-Sook YS, Kim, Eun-Joo EJ, Park, Ui-Hyun UH, Sin, Hong-Sig HS and Um, Soo-Jong SJ.. (2006) Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor.. The Journal of biological chemistry, (30): [PMID:16606617]
78. Zody, Michael C MC and 73 more authors.. (2006) DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.. Nature, (20): [PMID:16625196]
79. Li, Hui Joyce HJ, Haque, Zaffar K ZK, Chen, Amy A and Mendelsohn, Michael M.. (2007) RIF-1, a novel nuclear receptor corepressor that associates with the nuclear matrix.. Journal of cellular biochemistry, (1): [PMID:17455211]
80. Jimi, Shiro S and 5 more authors.. (2007) RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells.. International journal of oncology, [PMID:17611697]
81. Miwako, Ishido I and Kagechika, Hiroyuki H.. (2007) Tamibarotene.. Drugs of today (Barcelona, Spain : 1998), [PMID:17925887]
82. Tippmann, Frank F, Hundt, Jana J, Schneider, Anja A, Endres, Kristina K and Fahrenholz, Falk F.. (2009) Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, [PMID:19144697]
83. Qin, Zhen Z and 7 more authors.. (2009) ZNF536, a novel zinc finger protein specifically expressed in the brain, negatively regulates neuron differentiation by repressing retinoic acid-induced gene transcription.. Molecular and cellular biology, [PMID:19398580]
84. Zhu, Li L, Santos, Nadine C NC and Kim, Kwan Hee KH.. (2009) Small ubiquitin-like modifier-2 modification of retinoic acid receptor-alpha regulates its subcellular localization and transcriptional activity.. Endocrinology, [PMID:19850744]
85. Guyot, Romain R, Vincent, Séverine S, Bertin, Julie J, Samarut, Jacques J and Ravel-Chapuis, Patrick P.. (2010) The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR.. BMC molecular biology, (15): [PMID:20078863]
86. Santos, Nadine C NC and Kim, Kwan Hee KH.. (2010) Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling.. Endocrinology, [PMID:20215566]
87. Khurana, Simran S and 9 more authors.. (2012) Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.. The Journal of biological chemistry, (6): [PMID:22351778]
88. Natrajan, Muktha S MS and 10 more authors.. (2015) Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.. Brain : a journal of neurology, [PMID:26463675]

溶液计算器

摩尔浓度计算器

计算溶液所需的质量、体积或浓度。

质量

浓度

体积

分子量

g/mol

稀释计算器

计算配制储备溶液所需的稀释度。

浓度1（C1）

体积 1 (V1)

浓度 2 (C2)

体积 2 (V2)

复溶计算器

复溶计算器允许您快速计算试剂的体积，以复溶小瓶。只需输入试剂的质量和目标浓度，计算器将确定其余部分。

体积（添加到小瓶中）

质量（小瓶）

所需的复溶浓度

货号 (SKU)	包装规格	是否现货
Ab125108-10μl	10μl	现货
Ab125108-50μl	50μL	现货
Ab125108-100μl	100μL	期货
Ab125108-1ml	1ml	期货

Recombinant Retinoic Acid Receptor alpha Antibody

库存信息

库存信息

库存信息

库存信息

基本信息

产品属性

关联靶点（人）

作用机制

图片

应用

质检证书（CoA,COO,BSE/TSE 和分析图谱)

技术文档和文章

引用文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器

Recombinant Retinoic Acid Receptor alpha Antibody

库存信息

库存信息

库存信息

库存信息

基本信息

产品属性

关联靶点（人）

作用机制

图片

应用

质检证书（CoA,COO,BSE/TSE 和分析图谱)

技术文档和文章

相关产品

引用文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器